Orthofix Medical INC Form 4 insider transactions

Orthofix Medical Inc.'s CEO, Massimo Calafiore, reports acquisition and disposal of common stock and acquisition of employee stock options.

Geoffrey C. Gillespie, CAO of Orthofix Medical Inc., sold shares of common stock to satisfy tax withholding obligations related to the settlement of restricted stock units.

Orthofix Medical Inc. CFO Julie Andrews sold 4,655 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Orthofix Medical Inc.'s CEO, Massimo Calafiore, sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Geoffrey C. Gillespie, CAO of Orthofix Medical Inc., sold shares of common stock to satisfy tax withholding obligations related to the settlement of restricted stock units.

Orthofix Medical Inc.'s Chief Accounting Officer, Geoffrey C. Gillespie, sold shares of common stock to cover tax obligations related to the settlement of restricted stock units.

Orthofix Medical Inc. CAO Geoffrey C. Gillespie sold shares of common stock on December 17, 2024, to satisfy tax withholding obligations related to the settlement of restricted stock units.

Patrick Fisher, President of Global Orthopedics at Orthofix Medical Inc., reports acquisition of common stock and stock options.

Director Charles R. Kummeth reports acquisition of 15,152 shares and disposal of common stock of Orthofix Medical Inc.

Director Jason Hannon acquired 15,152 shares of Orthofix Medical Inc. common stock at $12.87 per share on June 18, 2024, and holds 44,790 deferred stock units.

Director Michael E. Paolucci reports acquisition of 15,152 shares of Orthofix Medical Inc. common stock and holds 66,766 shares following the transaction.

Director Shweta Maniar reports acquiring 15,152 deferred stock units in Orthofix Medical Inc.

Director John B. Henneman III reports acquisition of Orthofix Medical Inc. shares and updates on beneficial ownership.

Director Alan Lee Bazaar reports acquiring 15,152 shares of Orthofix Medical Inc. common stock and disposing of 24,088 deferred stock units.

Director Michael Finegan acquired 21,368 shares of Orthofix Medical Inc. common stock on June 18, 2024, and holds 29,718 deferred stock units.

Director Wayne Burris reports acquisition of Orthofix Medical Inc. shares and updates to beneficial ownership.

Max Reinhardt, President of Global Spine at Orthofix Medical Inc., reports acquisition of common stock and stock options.

Kimberley A. Elting, President of Global Orthopedics at Orthofix Medical Inc., reported the disposal of 4,267 shares of common stock to cover tax obligations.

Jorge Andres Cedron, CLO of Orthofix Medical Inc., reports acquisition of common stock and stock options.

Kimberley A. Elting, President of Global Orthopedics at Orthofix Medical Inc., reports disposing of 2,938 shares of common stock to cover tax obligations.

Director Catherine M. Burzik disposed of 47,486 shares of Orthofix Medical Inc. common stock to cover tax obligations.

Kimberley A. Elting, President of Global Orthopedics at Orthofix Medical Inc., reports the disposal of 2,031 shares of common stock to cover tax obligations related to restricted stock units.

Geoffrey C. Gillespie, CAO of Orthofix Medical Inc., reports the disposal of 70 shares of common stock to cover tax obligations.

Geoffrey C. Gillespie, CAO of Orthofix Medical Inc., reports acquisition of common stock and stock options.

Director Alan Lee Bazaar reports acquisition and disposal of Orthofix Medical Inc. common stock and deferred stock units.

Director Michael Finegan acquired 8,350 deferred stock units of Orthofix Medical Inc. on January 31, 2024.

Director Charles R. Kummeth acquired 8,350 deferred stock units of Orthofix Medical Inc. on January 31, 2024.